Gedatolisib Shows Superior Potency and Efficacy versus Single-Node PI3K/AKT/mTOR Inhibitors in Breast Cancer Models

Using multiple functional assays, a panel of breast cancer cell lines were evaluated for their sensitivity to four different PI3K, AKT, and mTOR inhibitors: gedatolisib, alpelisib, capivasertib, and everolimus.